增强肠道激素对年长成年人表现出低食欲的食反应
Aygul Dagbasi1, Jordan Warner2, Victoria Catterall2
1Section of Nutrition, Imperial College London, 6th Floor Commonwealth Building, Hammersmith Hospital, London, UK.
Appetite
|May 18, 2024
概括
胃口低下的老年人表现出对食物的厌食性肠道激素反应升高,这表明这些激素变化可能会导致与年龄相关的食欲丧失. 这项研究探讨了衰老厌食症中的肠道激素特征.
科学领域:
- 老年学是一门学科.
- 内分泌学 在内分泌学.
- 营养科学 营养科学
背景情况:
- 肠道激素的与年龄相关的变化与衰老的厌食症有关.
- 了解这些激素变化对于解决老年人的食欲下降至关重要.
研究的目的:
- 调查格林度,Y (PYY) 和类似葡萄糖-1 (GLP-1) 在老年人中,有或没有衰老厌食症.
- 为了比较肠道激素对老年人与低食欲 (OA-LA),健康食欲 (OA-HA) 和年轻人 (YA) 之间的食反应.
主要方法:
- 研究包括13个OA-HA,15个OA-LA和12个YA.
- 参与者吃了一顿标准的早餐,然后在240分钟内测量食欲和取血样.
- 在240分钟后消耗了一顿随意的午餐,并分析了摄入量和荷尔蒙反应 (ghrelin,PYY,GLP-1).
主要成果:
- 与YA和OA-HA相比,OA-LA的午餐消耗量显著减少.
- 与YA和OA-HA相比,OA-LA中饭后林抑制显著增加.
- 趋势表明OA-LA中GLP-1和PYY反应较高,有助于整体厌食性反应得分更高.
结论:
- 增加的厌食性肠道激素对食的反应可能是衰老厌食症背后的因果机制.
- 这些发现突显了肠道内分泌信号在与年龄相关的食欲减少中的作用.
相关概念视频
Regulation of Food Intake
220
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
220
Hormonal Regulation
43.4K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.4K
Glucagon-like Receptor Agonists
318
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
318
Hypoglycemia and Glucagon
256
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
256


